Ultimately, point-of-care simultaneous real-time measurements of insulin and blood glucose using biosensor technology can offer significant potential for minimising the impact of the impending diabetes epidemic and improve the quality of life of diabetic patients. Here, INS is linked to diabetes mellitus.